Bulletin
Investor Alert

Harrow Health Inc.

NAS: HROW

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 15, 2021, 4:00 p.m.

/zigman2/quotes/206805265/composite

$

9.89

Change

0.00 0.00%

Volume

Volume 515

Quotes are delayed by 20 min

/zigman2/quotes/206805265/composite

Previous close

$ 10.30

$ 9.89

Change

-0.41 -3.98%

Day low

Day high

$9.87

$10.43

Open

52 week low

52 week high

$4.65

$11.24

Open

Insider Actions for Harrow Health Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/24/2021 Richard L. Lindstrom
Director
3,900   Disposition at $10.04 per share. 39,156
09/16/2021 Richard L. Lindstrom
Director
5,840   Disposition at $9.02 per share. 52,676
09/15/2021 Richard L. Lindstrom
Director
14,160   Disposition at $9.09 per share. 128,714
08/19/2021 Opaleye Management, Inc.
2,500   Acquisition at $8.44 per share. 21,100
08/19/2021 Opaleye Management, Inc.
50,000   Acquisition at $8.44 per share. 422,000
08/18/2021 Opaleye Management, Inc.
1,500   Acquisition at $8.64 per share. 12,960
08/18/2021 Opaleye Management, Inc.
45,000   Acquisition at $8.64 per share. 388,800
08/17/2021 Opaleye Management, Inc.
1,000   Acquisition at $8.57 per share. 8,570
08/17/2021 Opaleye Management, Inc.
25,000   Acquisition at $8.57 per share. 214,250
07/21/2021 Opaleye Management, Inc.
4,706   Acquisition at $7.6 per share. 35,765
07/21/2021 Opaleye Management, Inc.
4,500   Acquisition at $7.6 per share. 34,200
07/20/2021 Opaleye Management, Inc.
125   Acquisition at $7.2 per share. 900
07/20/2021 Opaleye Management, Inc.
4,800   Acquisition at $7.2 per share. 34,560
07/19/2021 Opaleye Management, Inc.
169   Acquisition at $6.97 per share. 1,177
07/19/2021 Opaleye Management, Inc.
5,700   Acquisition at $6.97 per share. 39,729
06/18/2021 Opaleye Management, Inc.
3,522   Acquisition at $8.35 per share. 29,408
06/18/2021 Opaleye Management, Inc.
59,800   Acquisition at $8.35 per share. 499,330

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
12 Purchases
3 Sales
145,000
23,900
Last 6 months
17 Purchases
5 Sales
347,084
83,732
Last 12 months
25 Purchases
6 Sales
683,500
91,232

Officers and Executives

Mr. Mark L. Baum
Chairman & Chief Executive Officer
Mr. Andrew R. Boll
Chief Financial Officer & Secretary
Dr. Larry M. Dillaha
Chief Medical Officer
Mr. Andrew Livingston
Chief Innovation Officer
Mr. John P. Saharek
President-ImprimisRx
Dr. Richard L. Lindstrom
Director
Ms. Teresa F. Sparks
Independent Director
Dr. R. Lawrence Van Horn
Independent Director
Dr. Robert J. Kammer
Independent Director
Link to MarketWatch's Slice.